Our objective was to present current data pertaining to angiogenesis of the
uterine cervix. We conducted a computerized search to identify relevant st
udies published in the English language literature. MEDLINE, Current Conten
ts and Index Medicus were searched utilizing the terms: angiogenesis, uteri
ne cervix, intraepithelial neoplasia, squamous cell carcinoma, and adenocar
cinoma, from 1966 through June 1999. In contrast to the cyclic phases of th
e menstrual cycle of the ovary and endometrium in which angiogenesis plays
a significant physiologic role, angiogenesis in the uterine cervix is invol
ved primarily in neoplastic processes. These include intraepithelial diseas
e, human papilloma-related disease, and microinvasive and invasive squamous
cell and adenocarcinoma of the cervix. In invasive squamous cell and adeno
carcinoma of the uterine cervix, angiogenesis appears to be a prognostic in
dicator for overall survival and disease-free survival. Initial trial studi
es with anti-angiogenic (angio-inhibitor) therapy such as TNP-470 have been
reported and concurrent antitumor activity observed in a limited number of
patients with advanced (inoperable or metastatic) disease.